Search
for
Sort by
Research 31–60 of 1000+
- Hair loss due to treatment of multiple sclerosis
- Severe Alopecia Complicating Systemic Sclerosis
- Abstract 2469: Increased cathepsin B expression in cultured tuberous sclerosis skin tumor cells and patient tumor tissues
- Tuberous sclerosis: Clinical findings in 57 patients
- Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes
- Teriflunomide in multiple sclerosis: an update
- New developing multiple sclerosis in a patient using tofacitinib due to alopesia areata
- Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice?
- Paradise Nut Paradox: Alopecia Due to Selenosis from a Nutritional Therapy
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.
- Interfacial Adipose Tissue in Systemic Sclerosis
- Experimental Production of Cutaneous Calcinosis and Sclerosis with Dihydrotachysterol (AT-10) 1
- Alopecia Universalis in a Multiple Sclerosis Patient After Switching From Rituximab to Ocrelizumab: A Case Report
- Role of isoflavones in multiple sclerosis
- Exploring the Dermoscopic Patterns in Tuberous Sclerosis
- BH25 Alopecia in a patient undergoing multiple treatments for multiple sclerosis: a rare presentation and case review
- 3162 Alopecia universalis after alemtuzumab in multiple sclerosis - a nine year follow up and review of literature
- Capillaroscopic patterns in patients with systemic sclerosis, psoriasis and alopecia and their correlations with serum concentrations of several angiogenic markers
- The relationship of hair color to selenium content of hair and selenosis in swine
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Teriflunomide: A Once-daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis
- Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Does Post-Void Residual Volume Predict Worsening Urological Symptoms in Patients with Multiple Sclerosis?
- A different approach to hair analysis: Application to multiple sclerosis
- The Shifting Landscape of Disease-Modifying Therapies for Relapsing Multiple Sclerosis
- Erosive pustular dermatosis of the scalp and multiple sclerosis: just a coincidence?
- Post-marketing safety profile of cladribine in multiple sclerosis: a disproportionality analysis based on the FDA adverse event reporting system